NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹3.00 Cr | ₹0.40 Cr | ₹15 Cr | ₹8.00 Cr | ₹1.20 Cr |
What is the latest Contingent Liabilities ratio of NATCO PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹3.00 Cr |
| Mar2024 | ₹0.40 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹8.00 Cr |
| Mar2021 | ₹1.20 Cr |
How is Contingent Liabilities of NATCO PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.00 Cr | 650.00 | |
| Mar2024 | ₹0.40 Cr | -97.26 | |
| Mar2023 | ₹15 Cr | 82.50 | |
| Mar2022 | ₹8.00 Cr | 566.67 | |
| Mar2021 | ₹1.20 Cr | - | |
Compare Contingent Liabilities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,805.6 Cr | -0.8% | -4% | 0.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -0.8% |
-4% |
0.3% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses